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A B S T R A C T   
The development of a label-free, non-destructive and safe analytical method such as Raman spectroscopy for 
assessing cartilage degradation is highly desirable. Compared to non-optical imaging modalities, Raman mapping 
offers a more sensitive means of directly assessing the chemical composition of cartilage in three-dimensional 
space and the potential to monitor cartilage degeneration to inform intervention and treatment strategies. 
Herein, we report the application of Raman spectroscopic methods ex vivo and at arthroscopy to identify mo-
lecular alterations in cartilage specimens containing minor focal lesions characteristic of the early disease phase. 
Our initial ex vivo analysis, obtained by single-point Raman spectroscopy of cartilage samples, supports previous 
findings based on S-O stretching vibration bands associated with sulphated glycosaminoglycans (sGAGs). We 
extended the analyses to the high-wavenumber region where we observed that vibrational bands assigned to C-H 
and O-H stretching modes discriminated early cartilage alterations from healthy cartilage samples. Furthermore, 
we performed a proof-of-concept in-clinic study using a custom-built optical probe to acquire Raman spectral 
measurements for the first time in patients undergoing arthroscopy of knee joints. Spectra were obtained with 
adequate signal-to-noise ratios that similarly discriminated between lesion and adjacent cartilage sites and 
identified reductions in sGAGs in apparently healthy cartilage. Building on this, we present initial results from 
Raman mapping to spatially resolve the molecular constituents of cartilage through its depth and across a lesion. 
Mapping revealed a non-uniform and reduced sGAG distribution within the lesion and peripheral cartilage that 
was otherwise visually normal, similar to the in-clinic observations, showing that the degradative influence of the 
lesion extended beyond its border. This was accompanied by a decreased fluorescence signal intensity, which 
suggests that fluorescence may provide valuable information as an adjunct to the Raman signal in discriminating 
normal and degenerating cartilage. This work demonstrates the value of Raman mapping over single-point 
Raman measurements for the analysis of the anisotropy of articular cartilage and highlights the potential of 
the technology for in vivo articular joint arthroscopy applications.   
1. Introduction 
Diarthrodial joints are dependent on a thin layer of hyaline cartilage 
at their bony surfaces that enables near-frictionless movement and 
dissipation of the mechanical loads experienced during locomotion. 
Articular cartilage is a highly specialised tissue and structural lesions 
(fibrillations) that occur at its surface do not readily heal [1,2]. Such 
fibrillar lesions are considered to progress to osteoarthritis (OA), a dis-
ease characterised by the progressive loss of a smooth articulating sur-
face, pain, remodelling of joint tissues and eventual biomechanical 
failure of the joint [3,4]. OA is the leading cause of chronic disability in 
the elderly, with the knee and hip being most commonly involved, but it 
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can also affect other articular joints [5]. Worldwide it is estimated that 
9.6% of men and 18.0% of women over 60 years of age have symp-
tomatic OA, with approximately 80% of those experiencing limitations 
in joint movement and debilitating pain. Currently, no 
disease-modifying therapies exist. 
The characteristic physicochemical properties of articular cartilage 
are due to the highly ordered anisotropic structural organisation of its 
extracellular matrix (ECM), and variations in the distribution of chon-
drocytes and the molecular constituents of cartilage with depth have 
been reported [6]. Cartilage is generally subdivided into three structural 
zones based on the orientation of its collagen type II fibrils [7]. The 
major functional interactions occur between the two most abundant 
protein components, collagen type II and aggrecan. Aggrecan is a large 
proteoglycan (PG) that is densely substituted with sulphated glycos-
aminoglycan (sGAG) moieties. Fibrillar collagen forms a network that 
provides elastic restraint, whereas aggrecan is responsible for sustaining 
tissue hydration, which is necessary for compressive resilience, through 
the osmotic swelling pressure indirectly generated by the polyanionic 
sulphate (-OSO3-/-OSO3OH) group [8,9]. Cartilage function is compro-
mised by elastic weakening due to proteolytic cleavage of the collagen 
network resulting in fibrillation of the cartilage surface. Consequently, 
large structural alterations of the ECM occur, and these are considered to 
mark the point at which irreversible loss of cartilage commences [3,10]. 
It has been established via biochemical analysis that the earliest stages of 
OA are associated with aggrecan loss along with increased tissue hy-
dration [11–14] and are considered to be reversible [15–17]. Interven-
tion might prevent progressive cartilage damage if early disease stages 
could be identified. However, accurately identifying early molecular 
changes has proved challenging with the currently available method-
ology, and this hinders the development of disease-modifying OA drugs 
and other early-intervention treatment regimes. Of value would be the 
development of a spectroscopic technique calibrated to detect the 
biochemical and structural changes that occur prior to overt fibrillation 
of cartilage. 
X-ray transmission radiographic imaging is typically applied to di-
agnose OA by identifying narrowing of the articular joint space as an 
obvious indicator of cartilage erosion. The sensitivity of this approach is 
therefore limited to late disease stages, once significant and irreversible 
deterioration has already occurred [18]. Magnetic resonance imaging 
(MRI) provides direct morphological assessment of cartilage [19], with 
recent advances in contrast agents enabling quantitative biochemical 
approaches for imaging spatial distributions of PGs, tissue hydration and 
collagen organisation [20–23]. However, standard MRI techniques are 
not used routinely in the clinic due to cost considerations. Furthermore, 
incomplete penetration into the cartilage of the paramagnetic contrast 
agent necessary for quantitative imaging can hinder PG quantification 
[20]. Advances in developing and applying quantitative MRI (qMRI) 
techniques to assess cartilage damage and correlate these with changes 
in biochemical and biomechanical properties are progressing rapidly, 
although much of the work remains at an experimental stage [24,25]. 
Studies to develop predictive biomarkers for cartilage metabolites 
released into the circulation or synovial fluid have yielded promising 
results but these too remain to be fully validated [26,27]. 
Optical imaging and spectroscopic techniques are increasingly being 
developed to play a role in early assessment of cartilage disease and 
damage. These include optical coherence tomography (OCT) coupled 
with qMRI to yield through-depth characterization of the tissue [28]. 
Label-free second harmonic generation microscopy can provide addi-
tional detail on specific molecular components within the tissue [29]. 
However, although pathways exist for the in vivo implementation of 
these advanced optical techniques during surgery or pre-clinical 
assessment, they remain in the early stages of development. Deter-
mining suitable non-invasive markers of morphological and biochemical 
changes at the molecular level for early-stage cartilage disease that 
might facilitate the development of pharmaceutical treatment or pro-
vide better control over surgical intervention remains an important goal 
in the field [30]. 
The potential of optical spectroscopic techniques for the study of 
osteoarthritis at arthroscopy has recently been explored. For example, 
near-infrared spectroscopy has been demonstrated as a method for in 
vivo assessment of the biomechanical properties of equine cartilage [31]. 
Raman spectroscopy has been shown to be capable of identifying sys-
tematic changes in the vibrational spectra and relative intensities of 
specific biomarkers in cartilage biopsy samples correlated with Inter-
national Cartilage Repair Society (ICRS) OA grades [32–35]. Raman 
spectroscopy is a light scattering technique in which characteristic en-
ergy shifts (expressed in wavenumber units, cm–1) of an incident laser 
beam occurring as a result of interactions with vibrational modes of 
chemical species are measured. Thus, Raman spectroscopic analyses of 
biological specimens can be used to identify molecular signatures. 
Specific shifts associated with the primary macromolecular components 
of cartilage – collagen and aggrecan – have been identified in the spectra 
of excised cartilage samples [36]. sGAGs give rise to a characteristic 
band in the Raman spectrum in the 1060–1070 cm–1 range due to S-O 
stretching vibrations of the -OSO3-/-OSO3OH groups [36,37]. Initial 
studies in this area by us and others demonstrated a systematic intensity 
decrease for this band in the spectra of samples with progressively more 
severe OA classifications, indicating its potential value for assessing 
early-phase compositional changes within cartilage [32–35]. Other 
relevant Raman bands include those at 1380 cm–1 and 1424 cm–1, which 
have been tentatively assigned to CH3 and COO- vibrations, respectively, 
of GAGs [38]. However, within the field of osteoarthritis research, an-
alyses of Raman data outside the fingerprint region of the vibrational 
spectrum, in the high-wavenumber region, are lacking. 
In this study our first aim was to verify the validity of the use of the 
sGAG Raman band at 1063 cm–1 in determining the degeneration state 
of ex vivo human cartilage. The second aim was to evaluate the 
biochemical data encoded in the high-wavenumber region of the Raman 
spectrum by multivariate data analysis to identify clinically valuable 
systematic changes associated with cartilage degradation. Furthermore, 
we aimed to test the applicability of Raman spectroscopy at knee 
arthroscopy in patients. Because both the incident laser beams and 
Raman scattered photons have wavelengths in the visible-to-near-IR 
region of the spectrum, they can be readily focused on and collected 
from the sampling region of interest, including via specially designed 
arthroscopic probes based on fibre optics that can be implemented for 
intraoperative assessment during orthopaedic interventions [34,39]. 
Applying these principles, we were able to extend our observations to 
include initial results obtained during exploratory arthroscopic surgery. 
Finally, we demonstrated the value of Raman mapping techniques in 
spatially resolving molecular constituents of cartilage throughout its 
depth, overcoming the limitations of current techniques based on 
micron-order tissue sampling and establishing the importance of map-
ping across larger tissue areas. 
2. Materials and methods 
2.1. Biopsy sample preparation 
Cartilage samples from human femoral condyles were obtained 
following institutional ethics approval (Stanmore Musculoskeletal Bio-
bank, REC 09/H0304/78; RVC Ethics and Welfare Committee, URN 
2016 1467). Cartilage specimens for the ex vivo single-point spectros-
copy study were collected within 18 h following lower-limb amputation 
for osteosarcomas from knee joints not involved in the tumour pathol-
ogy. Those with an intact surface and glossy appearance without any 
macroscopic lesions (ICRS grade 0) were categorised as normal (control) 
specimens (n = 3, 36–60 years). Occasionally, in some of these appar-
ently healthy knee joints, small partial-thickness focal lesions of ~0.5–2 
cm2, which have been shown to exhibit characteristics of the biochem-
ical changes seen in OA [40], were observed in the cartilage. Cartilage 
samples from these were taken from sites adjacent and distal to the 
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lesion (Supplementary Fig. 1a). In some instances, normal cartilage and 
cartilage with lesions was sampled from the same specimen for the 
single-point Raman spectroscopy study (Supplementary Table 1). 
Cartilage specimens with lesions were classified as degenerative, with 
those having either a small area of surface roughening with loss of glossy 
appearance as grade 1 (n = 3, 36–66 years) or those with a partial-depth 
erosion as combined grades 2/3 (n = 4, 38–66). Residual cartilage 
specimens from total knee replacement (n = 2, 59 and 68 years) were 
also analysed and classified as late-stage OA (grade 4). An additional 
grade 4 sample (66 years) was used for the biochemical assays. 
Full-depth cartilage specimens were prepared to include the synovial 
surface and subchondral bone. Specimens were washed in Dulbecco’s 
modified Eagle’s medium (Thermo Fisher Scientific Inc., UK) to remove 
residual synovial fluid and blood before biochemical analysis, snap- 
freezing for histology or storage at –80 ◦C until experimental analysis. 
Specimens were prepared for biochemical analysis of sGAG and water 
content (with the subchondral bone removed), as well as for histology 
and Raman microspectroscopy. Full-depth cartilage specimens used for 
Raman spectroscopy mapping studies were embedded in optimal cutting 
temperature compound (Tissue-Tek® O.C.T.™, Sakura Finetek Europe 
B.V., Netherlands). Cryosections of 20 μm thickness were mounted on 
super mirror stainless steel slides (Thames Stockholders Ltd, Middlesex, 
U.K.) that had been previously shown to be Raman compatible [41,42] 
and the optimal cutting compound was removed using deionised water 
prior to Raman spectroscopy or imaging. 
2.2. Biochemical assay and histological staining 
sGAG assays were performed on specimens of full-depth cartilage 
(approximately 10–50 mg) ICRS G0 (n = 3), G1 (n = 3), G2/3 (n = 4) and 
G4 (n = 3) specimens (Table 1). The cartilage was cut into 20 μm cry-
osections and proteoglycans were extracted with 10 volumes of buffer (4 
M guanidium chloride, 50 mM sodium acetate, 10 mM EDTA, pH 6.8) for 
24 h at 4 ◦C and cleared extracts were assayed for sGAG using the 
dimethylmethylene blue method [43]. Snap-frozen cartilage was cry-
osectioned at 5 μm (Bright cryostat), and then stained with safranin O. 
Water content was measured by tissue weight before and after lyophi-
lisation of samples for 24 h (Heto Maxi Dry, Thermo Scientific). An 
unpaired Student’s t-test was applied for the statistical analysis and a p 
value of 0.05 or less was considered significant. 
2.3. Raman microspectroscopy 
2.3.1. Single-point spectroscopy of synovial surface of cartilage biopsies 
An inVia Raman microspectroscopy instrument (Renishaw plc, 
Wotton-under-Edge, UK) equipped with a 785 nm laser was used for our 
initial studies of excised cartilage tissue as well as for acquisition of 
collagen and aggrecan samples [33,44]. The choice of near-IR laser 
excitation for such measurements has been discussed previously [34,35, 
44]. The incident beam was focused on the synovial surface of the 
sample to collect data using a Leica 50×/0.5 N.A. long working distance 
microscope objective. The laser power was measured to be ~15 mW at 
the sample, which is sufficiently low to avoid laser-induced degradation. 
Four spectral acquisitions (15 min total collection time) were averaged 
for each sample. In initial experiments, cartilage samples were immersed 
in synovial fluid or deionised water during measurements to assess the 
influence of the use of different fluids on spectral acquisition. The in-
fluence of freezing was also examined by comparing spectra from fresh 
cartilage samples and samples thawed following −80 ◦C storage. No 
major differences between these spectra were observed (Supplementary 
Fig. 2) and all subsequent ex vivo spectral acquisition was carried out in 
water after thawing stored frozen cartilage. 
2.3.2. Raman mapping of full-depth cartilage sections 
Raman imaging of excised cartilage tissue sections was carried out 
using the Renishaw StreamLine™ image acquisition tool within a RA816 
Biological Analyser system equipped with imaging capability (Renishaw 
plc, Wotton-under-Edge, UK). Maps were obtained covering the full 
depth of cartilage from three locations: 1) within a lesion area, 2) 
adjacent to the lesion and 3) distal site to the lesion (apparently normal 
cartilage) from a 47 year specimen (Supplementary Fig. 1a). The lesion 
map consisted of 30,530 individual spectra, acquired using a 20 μm step 
size, encompassing most of the eroded surface over the full cartilage 
depth, extending into the subchondral bone. Smaller maps of the adja-
cent and distal sites consisted of approximately 15,000 individual 
spectra acquired using a 3 μm step size. Maps were also obtained for 
cartilage sampled from a joint with no lesions as a control (18 years) 
which consisted of approximately 19,000 individual spectra. All maps 
were acquired using a 785 nm laser line and 50×/0.75 N.A. short 
working distance objective delivering 158 mW of laser power onto the 
sample surface over a pixel dwell time of 3 s. A significantly higher laser 
power was used for the mapping studies compared to the point mea-
surements because during mapping the laser beam was line focused such 
that it illuminated a large surface area of the sample; thus the optical 
power density at the sample remained low, reducing the likelihood of 
photothermal degradation. The RA816 system was limited to the 
0–3000 cm–1 Raman shift range and hence we were unable to image the 
high-wavenumber region extending beyond 3000 cm–1. 
2.4. Reference Raman spectra from laboratory-grade chemicals 
Reference Raman spectra representative of the main cartilage con-
stituents were collected from chondroitin sulphate A sodium salt, 
collagen and synthetic hydroxyapatite (Sigma-Aldrich Inc. Dorset, UK) 
using a Renishaw R816 Biological Analyser A total of five spectra were 
acquired for each chemical sample from different areas within the 
sample, using a 10 s acquisition time per measurement, and then an 
average was taken across all the measurements to obtain the reference 
spectrum. 
2.5. Arthrospectroscopic in-clinic studies 
2.5.1. Optical probe design 
For implementation of the Raman spectroscopy technique during 
surgical procedures, an optical probe was engineered to deliver and 
focus the incident laser and collect the Raman scattered signal from the 
region of interest. The probe was designed to be compatible with tech-
niques and instrumentation used for knee arthroscopy (Supplementary 
Fig. 3). The aim was to transmit laser light from an optical fibre to the 
end of a 6 mm outer-diameter steel cylinder that could be used as an 
arthroscopic tool to deliver the laser beam onto the cartilage surface 
within the knee and collect the backscattered photons. 
The optical probe was machined from 316 L S16 steel with a main 
body length of 100 mm to include a threaded connector, a sapphire lens 
(Edmund Optics, UK) to focus the laser beam and an endcap with a 4.5 
mm diameter sapphire window (Edmund Optics, UK) (Supplementary 
Fig. 3a). The lens was positioned within the probe such that the focal 
point of the laser was at the exit of the sapphire window, enabling focus- 
Table 1 
Biochemical analyses of sGAG and water contents in cartilage samples.  
Gradeg Total sGAGh Content 
(μg/mg dry wt.)i 
Water Content 
(% dry wt.)i 
G0 (n = 3) 140.2 ± 18.2 73.1 ± 0.95 
G1 (n= 3) 132.0 ± 12.4 71.2 ± 0.80 
G2/3 (n = 4) 102.8 ± 18.7* 78.6 ± 1.25* 
G4 (n = 3) 92.0 ± 22.1* 77.2 ± 1.86**  
* p < 0.05 for the difference from grade 0. 
** p < 0.05 for the difference from grades 0 and 1. 
g G0 to G4 denote grades 0 to 4. 
h sGAG, sulphated glycosaminoglycan. 
i Values represent mean ± 1 s.d. 
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free use of the probe at arthroscopy. Both full-ball and half-ball lensing 
solutions were initially trialled in ex vivo experiments, with best results 
obtained using a single full-ball lens designed to deliver 15–30 mW of 
laser power to the sample surface. The lens and sapphire window were 
fixed in position with Loctite M31-CL epoxy adhesive (Henkel Ltd, Herts, 
UK), which meets the ISO 10993 biocompatibility standard for medical 
devices and is resistant to ethylene oxide sterilisation. The probe was 
coupled to a Renishaw inVia system with 785 nm laser excitation and 
fibre optic delivery for initial trials (Supplementary Fig. 3b). 
2.5.2. In-clinic investigation 
Implementation of the probe was first optimized on cadaver joint 
specimens under research ethical approval obtained from the Integrated 
Research Application System (IRAS) (10/H0711/2) and the RVC Ethics 
and Welfare Committee (2010 0004 H). The main aim was to determine 
that spectra with acceptable signal-to-noise characteristics could be 
acquired both within a reasonably short time, to minimize the burden on 
patient and surgeon (i.e., less than 2 min per collection point), and 
within the constraints of an optical probe that had a size and shape 
compatible with standard arthroscopic surgical procedures. These initial 
experiments enabled the manipulation and familiarisation of the hand-
held optical arthroscopy probe by the surgeon for positioning within the 
knee joint. The window of the probe was carefully abutted against the 
cartilage at specific locations on the femoral condylar cartilage before 
the arthroscope light was switched off for acquisition of Raman spectra. 
These experiments also allowed us to determine the optimal conditions 
for spectral acquisition and verify the minimum time for acquisition of 
spectra with reasonable signal-to-noise levels without burden to the 
patient or surgeon (2 min). Spectra were obtained under minimal room 
lighting conditions, with the operating theatre lights switched off. 
Interference from background lighting (essential theatre instruments 
and video monitors) was minimised by using blackout drapes to cover 
the spectral acquisition area immediately before spectra were acquired. 
Following measurement optimisation, four patients undergoing 
exploratory arthroscopy of the knee for suspected cartilage defects were 
recruited following informed consent and study approval (Imperial 
College NHS Trust Research Ethics Committee 10/H0711/2). The 
cartilage lesions observed at arthroscopy were visually graded using the 
Outerbridge classification [45] (Supplementary Table 2). The probes 
underwent ethylene oxide sterilisation before Raman spectroscopy 
measurements were performed at arthroscopy for each patient under 
Hartmann saline lavage and distension of the knee joint, with the 
camera portal light as well as theatre and non-essential instrument 
lighting switched off (Supplementary Fig. 3c). Interference from essen-
tial lighting was minimised by covering the spectral acquisition area 
with blackout drapes during the acquisition. All joints exhibited an area 
of partial erosion of the femoral condyle cartilage of approximately of 4 
to 6 cm2. A series of spectra with acquisition times of 2 min each were 
obtained from two sites: (i) within fibrillated cartilage and (ii) at a 
distance of 10–15 mm from the fibrillating cartilage within the adjacent 
macroscopically normal cartilage. The effect of the theatre and instru-
ment lighting was evaluated prior to these measurements. 
2.6. Analysis 
2.6.1. Pre-processing 
Cosmic ray artefacts were first removed from all datasets using the 
zap feature within the WiRE 5 software package (Renishaw plc, Wotton- 
under-Edge, UK). Raman spectra of cartilage sections were initially 
collected over a range of spectral shifts from the incident laser line from 
~40–4000 cm–1. For the data analysis, the spectra were typically 
segregated into two regions: (i) the fingerprint region (450–1800 cm–1) 
and (ii) the high-wavenumber region (2500–4000 cm–1). Spectra were 
then imported into Matlab R2017a (MathWorks, Natick, MA, USA), 
baseline corrected using the adaptive min-max routine described by Cao 
et al. [46] and vector normalised such that the intensity at each 
frequency in the spectrum was divided by the square root of the sum of 
the squares of all the intensities, where the sum was over all frequencies 
[46]. The adaptive min-max method was implemented as it has previ-
ously been shown to provide significantly better results than any single 
polynomial fit and is more amenable to implementation in an automated 
real-time in vivo Raman platform. The Raman mapping datasets under-
went the same pre-processing steps. Spectra acquired in vivo during 
in-clinic tests underwent an additional smoothing step using a Savitz-
ky–Golay filter with a smoothing window of 11 and a second-order 
polynomial. 
2.6.2. Empirical data analysis 
Our initial detailed analysis of the spectral region of interest (ROI) 
spanning 985–1120 cm–1 was aimed at examining systematic variations 
in the intensity of the sulphate (-OSO3-) S-O stretching band at 1063 
cm–1 calibrated against the intensity of the dominant sharp band at 1003 
cm–1 assigned to phenylalanine residues; these two bands are common 
to both the collagen and aggrecan components of cartilage. Within the 
broader spectral band between 985 and 1120 cm–1, we fitted seven 
subbands to mixed Gaussian−Lorentzian functions using the WiRE 5.0 
software (Renishaw plc, Wotton-under-Edge, UK). Each subband was 
identified using Savitzky–Golay differentiation filtering with a second- 
order polynomial and first-order derivative. Subband areas were then 
exported into a spreadsheet and band area ratios A1063/A1003 were 
calculated by dividing the 1063 cm–1 band area by the 1003 cm–1 band 
area for each specimen. The same approach was applied to the analysis 
of the spectra obtained during in vivo investigations. For the statistical 
analysis of the groups, one-way ANOVA was applied (non-parametric, 
Kruskal–Wallis test). Dunn’s multiple comparison post-test was carried 
out to determine statistically significant differences between groups. A p 
value of 0.05 or less was considered significant in all statistical tests. 
2.6.3. Multivariate data analysis 
A multivariate approach was applied to the same spectral datasets 
used in the initial examination of the spectral ROI described above, but 
in this case the entire recorded wavenumber range was considered. 
Difference spectra were computed and principal component analysis 
(PCA) was carried out in MATLAB using the IRootLab toolbox [47]. 
Difference spectra were obtained by averaging the spectra for each OA 
grade and subtracting the normal (grade 0) spectrum as a reference 
point from each grade. PCA was used to evaluate the factors affecting the 
spectral variation across the sample groups. This analysis was based on 
the correlation matrix of the original dataset and involved the rotation of 
the data matrix such that a new set of principal component axes (PCs) 
were produced to maximise the variance within the dataset [48]. With 
this approach the largest variance lies on the first axis, and the variance 
decreases thereafter for each successive axis. As a result PCA enables the 
separation of sample groups based explicitly on their unique biochem-
ical profile. 
Full-depth Raman maps obtained from cartilage sections were ana-
lysed using the WiRE 5.0 software and heat maps showing the fluores-
cence and sGAG distributions were generated from each specimen 
dataset. The tissue fluorescence was quantified as the total area under 
the Raman spectral bands that had been extracted from the raw Raman 
spectra as background. To gain an insight into the spatial distribution 
and general abundance of sGAG, direct classical least squares (DCLS) 
component analysis was used. This algorithm approximates the spec-
trum at each point in the map by summing together scaled copies of each 
input reference spectrum. Given that this approach requires that refer-
ence spectra for all components in the sampled mixture are used as in-
puts, we inputted spectra of the most abundant (non-aqueous) 
components of articular cartilage – collagen, aggrecan (chondroitin 
sulphate sodium salt) and hydroxyapatite. An optimal cutting com-
pound reference spectrum was also used as contamination from histo-
logical processing was observed. Water was not used as a reference input 
as dry tissue sections were imaged in this part of the study. 
R. Gaifulina et al.                                                                                                                                                                                                                               
Clinical Spectroscopy 3 (2021) 100012
5
3. Results and discussion 
3.1. Examining relative intensity changes in the sGAG characteristic 
Raman band with cartilage degeneration 
Spectra from points across the synovial surface of cartilage speci-
mens were recorded over the Raman shift range of 200 to 4000 cm–1 
(Fig. 1a). These consisted of a series of bands in the fingerprint region, at 
approximately 400–1800 cm–1, characteristic of the collagen, aggrecan 
and other components of cartilage [44]. In addition, in the 
high-wavenumber region, we observed a broad O-H stretching band at 
~3250 cm–1 due to the presence of molecular water incorporated into 
the tissue and an aliphatic C-H stretching band slightly below 3000 
cm–1. 
Following baseline subtraction, systematic changes in the relative 
band intensities occurring as a function of cartilage degradation became 
more apparent (Fig. 1b). Our initial investigation focused on the 1063 
cm–1 S-O stretching band of sGAG, which is an abundant moiety of 
aggrecan that is known to be lost in the early phases of cartilage 
degradation [10,11]. The intensity of this band decreased with 
increasing cartilage degeneration. This observation was consistent with 
the biochemical analysis of cartilage specimens (Table 1) and the his-
tology of tissue samples prepared from normal and lesion-site cartilage 
(Supplementary Fig. 1b). It was also apparent that the intensity of the 
1063 cm–1 band decreased relative to those of the other bands in the 
spectrum with lesion grade (Fig. 1b), suggesting a decrease in the sGAG 
moiety. To quantify the relative intensity changes, the 985–1120 cm–1 
region was curve fitted using a series of mixed Gaussian−Lorentzian 
functions (Fig. 1c). The results of the Kruskal−Wallis test were signifi-
cant (H = 16.9, 3 d.f., p = 0.0007), indicating a statistically significant 
difference between the lesion grades. Although there appeared to be a 
systematic decrease in the A1063/A1003 band area ratio with increasing 
lesion grade, pairwise comparisons using Dunn’s post-hoc tests indi-
cated statistically significant differences only between grades 0 and 4 (p 
= 0.01), grades 1 and 4 (p = 0.00004) and grades 2/3 and 4 (p = 0.03) 
(Fig. 1d). An overall decrease in the A1063/A1003 ratio from 1.69 (grade 
0) to 0.99 (grade 4) was observed, which indicates that this ratio has 
potential value as a marker for advanced degeneration state. However, 
the ability to distinguish between normal cartilage and cartilage from 
late-stage disease has limited clinical value because advanced disease 
can be readily diagnosed by alternative imaging modalities such as 
radiology or MRI. Thus, a univariate data analysis approach utilising a 
single band ratio may be insufficient to identify earlier stages of disease. 
Whereas it was possible to use the A1063/A1003 band area ratio to 
discriminate grade 4 cartilage from each of the other cartilage grades, a 
number of underlying data processing limitations hinder the use of this 
approach to assess the degree of cartilage deterioration. First, there are 
no standardised methods for pre-processing Raman spectra of biological 
origin, and this is particularly problematic with regard to baseline 
correction methods [46,49,50]. Baseline ‘over-correction’ can critically 
alter underlying spectral profiles, changing band heights and widths 
[51]. Overcorrection by subtracting a polynomial of order greater than 
Fig. 1. Raman spectra acquired from cartilage specimens. Macroscopically normal cartilage and cartilage with small focal lesions underwent single-point Raman 
spectroscopic analysis. The spectra shown are averages of a minimum of three acquisitions. a) Averaged Raman spectra obtained from cartilage graded from 0 to 4 
(ICRS grades 0 to 4) with standard deviations indicated by the shaded areas. b) Baseline-corrected Raman spectra in the fingerprint and high-wavenumber regions. 
The 1063 cm–1 S-O stretching band assigned to the -OSO3-/-OSO3OH groups of sulphated GAGs (sGAGs) is highlighted by the shaded vertical bar. c) Example 
spectrum with mixed Gaussian−Lorentzian functions fitted to the 1063 cm–1 sGAG band (red line), the phenylalanine ring breathing mode as an internal standard at 
1003 cm–1 (red line) and adjacent bands (grey lines). d) Dot plot showing 1063/1003 cm–1 band area ratios versus lesion grade, with diamonds depicting group 
means. Statistically significant differences between lesion grades and the associated p values are shown above the dots. 
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five is documented to cause distortions in spectral profiles and introduce 
artefacts [51]. Second, the validity of an internal spectroscopic cali-
bration standard such as the phenylalanine 1003 cm–1 band is ques-
tionable because of potential undefined changes to the profile of the 
band as a result of global molecular changes in cartilage with disease 
progression, age and tissue depth. Finally, in our averaged spectra, the 
O-H stretching intensity assigned to molecular H2O was shown to in-
crease with lesion severity (Fig. 1b). This suggests that the overall hy-
dration level of the sGAGs varies with lesion grade, which may have an 
unpredictable influence on the profile associated with the 1063 cm–1 
band [52]. Because of these considerations, we expanded our analyses of 
the Raman spectroscopy data to include assessment of the full wave-
number region including the high-wavenumber bands associated with 
O-H and C-H stretching vibrations. 
3.2. Examining spectral features across the full wavenumber range 
To better identify additional spectral changes occurring as a function 
of cartilage degeneration state, we attempted a multivariate data anal-
ysis approach in which spectral changes across the entire wavenumber 
range were considered. As a first multivariate data analysis approach, 
we analysed difference spectra obtained for the three sample groups 
(grades 1, 2/3 and 4) relative to the grade 0 control group (Fig. 2). 
Similar to the findings of the 1063 versus 1003 cm–1 band ratio analysis, 
we observed an intensity increase in the 1063 cm–1 S-O stretching band 
for the earliest lesion grade cartilage (grade 1) with respect to the 
control (Fig. 2a). Several other bands were also elevated in this region, 
and these increases were particularly marked for the bands above 1300 
cm–1. An elevation of the sGAG content and the contents of other protein 
constituents at this early lesion grade would suggest an increase in the 
synthesis or accumulation of some cartilage components, which might 
indicate a mechanism for the initial reparative processes occurring early 
in OA [53]. In response to tissue damage, chondrocytes appear to 
compensate by active proliferation and enhanced synthesis of matrix 
components including sGAGs [53–55]. We propose that failure of the 
reparative process causes a shift towards elevated catabolism, with 
cartilage destruction ensuing as evidenced by the large intensity 
reduction for multiple bands across the fingerprint region at more 
advanced lesion stages (Fig. 2b, c). 
Interestingly, in addition to the changes in band intensities, we 
observed a broad fluorescence feature spanning 600–850 cm–1 that 
increased in intensity with cartilage lesion grade (Fig. 2b, c, arrow). 
Biological materials inherently produce strong background fluorescence 
signals that can interfere with weaker Raman signals. Typically, fluo-
rescence can be diminished or eliminated by the use of a 785 nm laser 
excitation source, as was the case in our work. However, because of the 
pattern of growth observed for the fluorescence signal with lesion pro-
gression, we concluded that this broad fluorescence was related to a 
specific aspect of the degeneration occurring in the cartilage specimens. 
Although we are not certain about the source of the fluorescence, we 
speculate that it may be related to advanced glycation end products 
(AGEs) [56,57], and the strength of fluorescence signals as a measure of 
general cartilage degradation has been recognised in an auto-
fluorescence lifetime study [58]. 
In the high-wavenumber region, a similar trend was observed in 
cartilage of grade 1 and above in which a systematic decrease in the 
intensity of the CH stretching vibration band (2800–3000 cm–1) was 
accompanied by enhanced intensity in the O-H stretching region 
(3000–3600 cm–1) (Fig. 2d). These alterations correlate with the loss of 
tissue constituents and observed increase in water content (Table 1 and 
Fig. 2. Difference spectra in the fingerprint and high-wavenumber regions. Differences are shown between a) grade 1 and normal (grade 0) cartilage, b) grade 2/3 
and normal cartilage, c) grade 4 and normal cartilage and d) each lesion grade and normal cartilage in the high-wavenumber region. The growth in intensity between 
grade 2/3 and grade 4 of a difference feature arising from increased fluorescence in the 600–850 cm–1 range is indicated with arrows in b) and c). 
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Supplementary Fig. 1b), demonstrating an increase in cartilage hydra-
tion observed through the elevation of the O-H stretching band intensity. 
This is in agreement with the notion that the weakening of peptide 
bonds within the ECM, accompanied by the loss of sGAGs, results in 
structural disorganisation of the collagenous network. This loss of 
structural order is manifested by the breakdown of both the intra- and 
inter-molecular bonds in the helical part of collagen molecules, which 
can be correlated with observed increases in the total water content of 
OA cartilage [9,55]. 
By applying PCA to data acquired from the fingerprint region, we 
were able to distinguish only the more advanced (grade 4) cartilage from 
the other specimens (the healthy control and grades 0, 1 and 2/3) 
(Fig. 3a). The associated loading plot showed that the control and early 
lesion stages were characterised by the sGAG band at 1063 cm–1 
assigned to S-O stretching, a band at 1426 cm–1 associated with the 
COO- vibration and a disulphide stretching band at 531 cm–1 that 
probably originates from the disulphide bridges of ECM proteins 
(Fig. 3b). In addition, the control and early lesion cartilage featured 
several protein bands including those at 570 cm–1 (tryptophan), 856 
cm–1 (C-C stretching, proline), 879 cm–1 (C-C stretching, hydroxypro-
line), 920 cm–1 (C-C stretching, proline ring), 939 cm–1 (collagen, C-C 
stretching, proline in alpha helix), 1003 and 1033 cm–1 (phenylalanine 
ring breathing vibrations), 1098 cm–1 (C-N stretching, proteins), 1245 
and 1270 cm–1 (amide III bands and N-H bending vibrational modes) 
and 1451 cm–1 (assigned to methylene deformation in biomolecules [34, 
38,59–61]). This suggests that the total biomaterial concentration, and 
in particular the protein content, is significantly higher in the control as 
well as at the early lesion stages compared to the grade 4 lesions 
(late-stage disease). This is consistent with the higher rate of catabolism 
associated with the later stages of cartilage disease and the concomitant 
loss of tissue components observed in the difference spectra in Fig. 2b, c. 
By contrast, the spectra of the late-stage disease cartilage were 
dominated by water bands at 1622 and 1645 cm–1. These bands are 
thought to be assigned to the H-O-H vibrations of partially hydrogen- 
bonded (three-bonded) and fully hydrogen-bonded (four-bonded) 
water [62,63], which are involved in the conformation and stabilisation 
of fibrillar collagen [64]. This suggests that the molecular water signa-
tures may be associated with fibrillar collagen type II within the carti-
lage. Late-stage disease cartilage also featured strong bands centred at 
489 and 800 cm–1 for which the exact assignment is not yet clear, 
although it is possible that these bands originate from the molecular 
products of cartilage degradation. A prominent collagen band at 831 
cm–1 and a carbonyl vibration band at 1702 cm–1 characteristic of pro-
teins were also seen [61,65] (Fig. 3b). 
The high-wavenumber region of the Raman spectrum is known to 
contain bands of lesser molecular specificity but higher signal intensity 
[65]. PCA of this region indicated that it was possible to discriminate the 
grade 0 control group from the earliest signs of pathology represented by 
the grade 1 specimens (Fig. 3c). The control group was characterised by 
bands at 2951 and 2995 cm–1, which were tentatively assigned to ν(CH3) 
modes of proteins, while the grade 1 lesions were characterised by bands 
at 2852, 2874 and 2917 cm–1 tentatively assigned to ν(CH2) and ν(CH3) 
modes of lipids [65,61] (Fig. 3d). This result indicates that by examining 
the high-wavenumber region, it is possible to discriminate OA at 
significantly earlier stages in terms of changes in the vibrational signa-
tures of methylene and methyl groups. Although the exact molecular 
origin of these differences is yet to be determined, this observation holds 
promise for clinical application following further development and 
Fig. 3. Principal component analyses of the spectra in the fingerprint and high-wavenumber regions. a) One-dimensional PC1 score plot for the fingerprint region 
spectra of each lesion grade and b) corresponding PC1 loading plot. c) One-dimensional PC4 score plot for the high-wavenumber region spectra of each lesion grade 
and d) corresponding PC4 loading plot. In a) and c) the small symbols indicate individual spectra and the larger bold symbols show the spectral mean. 
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validation. A comprehensive list of tentatively assigned Raman bands 
can be found in Supplementary Table 3. 
3.3. Raman spectroscopy of knee joint cartilage at arthroscopy 
Having demonstrated the power of Raman spectroscopy to identify 
changes in cartilage composition that may be clinically meaningful, we 
investigated the potential to retrieve real-time Raman spectra in an in- 
clinic feasibility study, which is a first of its kind for knee joint 
arthroscopy to our knowledge. Prior to carrying out the in-clinic tests, 
the arthroscopic optical probe was trialled on cadaveric specimens 
(intact knees). It was determined that interpretable spectra could be 
obtained within 2 min, which might be acceptable in a clinical setting 
(data not shown). 
In the theatre, the sterilised arthrospectroscopic probe was con-
nected to the fibre-optic output of the spectrometer and positioned in the 
joint against the cartilage. This enabled single-point spectra to be ac-
quired both from cartilage that appeared macroscopically normal and 
from obvious lesions at arthroscopy (Fig. 4 and Supplementary Fig. 3). 
These spectra, and in particular the prominent phenylalanine ring 
breathing vibrational band at 1003 cm–1 (Fig. 4), demonstrate that it is 
possible to obtain Raman spectra with adequate signal-to-noise levels in 
a clinical setting. 
Sulphate and phenylalanine band area ratios, A1063/A1003, were 
calculated for the spectra obtained from each patient to compare be-
tween apparently morphologically normal cartilage (N) and eroding 
cartilage (L). The A1063/A1003 ratio was found to be below 1 in the 
eroding cartilage in three patients (patients 1, 2 and 3, with A1063/A1003 
ratios of 0.12, 0.44 and 0.63, respectively). From the ex vivo analysis, we 
know that these low A1063/A1003 ratios are most probably associated 
with the reduction in sGAG concentration in areas of cartilage erosion 
(Fig. 4a–c). Whist this was not an unexpected finding, it was interesting 
to note that this ratio was also observed to be reduced in cartilage that 
was apparently visually normal in patient 2 (A1063/A1003 ratio of 0.57, 
Fig. 4b) and patient 3 (A1063/A1003 ratio of 0.14, Fig. 4c). This is of 
significance because loss of proteoglycans prior to overt fibrillation of 
the cartilage surface has been established in vivo in models [66,67]. This 
suggests that in vivo disease-associated molecular changes extend into 
the cartilage immediately adjacent to the lesion margin that otherwise 
appears macroscopically normal and is deemed mechanically normal at 
arthroscopy. These subtle primary changes potentially could progress to 
full lesions [2] and result in the formation of larger lesions. Thus, the 
ability to identify such changes non-destructively would be a valuable 
tool to inform surgical decisions or interventions. 
By contrast, patient 4 showed an elevation in the A1063/A1003 ratio at 
the lesion site compared to that at the macroscopically normal cartilage 
site (Fig. 4d). Although the reason for this is not clear, one possible 
explanation is that this spectrum was acquired from a region of lesion 
site cartilage that was undergoing an active reparative process in 
response to tissue damage, resulting in enhanced synthesis of matrix 
molecules [53]. Alternatively, this increased band ratio could have 
arisen because of a heterogeneous distribution of sGAGs throughout the 
cartilage, as reported by Williams et al. [23]. We acknowledge that the 
small number of patients tested in this study places limitations on the 
Fig. 4. Spectra obtained from in-clinic tests. Prior to collection of the Raman spectra under minimal room lighting, the optical probe was positioned against the 
femoral condyle cartilage surface within the knee of four patients, a)–d), respectively. Raman spectra collected from regions of cartilage that were visually normal but 
within 10–15 mm of eroding regions are shown in black (N). Raman spectra collected from areas of partial erosions (lesions) are shown in red (L). Shaded vertical 
panels highlight the ring breathing vibration of phenylalanine at 1003 cm–1 and the ν1 vibrational mode of the sulphate -OSO3- group at 1063 cm–1. Area ratios for 
these two bands, A1063/A1003, were calculated and are shown alongside the respective spectra. Details of patient clinical features are given in Supplementary Table 2. 
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extrapolation of the data. However, the additional information gained 
from this proof-of-concept study highlights the insufficiency of using a 
single band ratio (such as the 1063 cm–1/1003 cm–1 ratio) for predictive 
or diagnostic classification. Thus, we emphasise the need to utilise a 
larger portion of the spectrum that encompasses a multitude of bands, as 
demonstrated by the superior classification achieved using the water 
bands in the high-wavenumber region (Fig. 3c). Because of the limited 
number of observations of Raman spectra from patient knees, we did not 
attempt to perform a multivariate evaluation. Nonetheless, these pre-
liminary results are of significance as they demonstrate that Raman 
spectroscopy using optical spectroscopic probes compatible with 
established arthroscopic techniques can be implemented to play a useful 
role during orthopaedic surgery. 
In the current work a linear optical probe design was used as this was 
Fig. 5. Raman mapping study of cartilage. Raman maps were obtained from cartilage sections prepared in the sagittal plane (synovial surface to bone) to generate 
spectral maps of the full depth of the cartilage. A normal cartilage section (control) was prepared from the medial femoral condyle of an 18-year-old donor. Sections 
were also prepared from a joint containing a partial-thickness focal lesion in the medial femoral condyle (47-year-old donor). Additional sections were prepared from 
the same joint, from cartilage bordering the lesion (adjacent) that otherwise appeared macroscopically normal and from a more distal site on the femoral condyle that 
was used as an intra-joint control (see Supplementary Fig. 1 for details of sampling sites). a) Brightfield images of unstained sections of distal, adjacent and lesion site 
cartilage and control (normal) cartilage. Regions of residual bone, erosion and small creases (tissue folds generated in the lesion site sample during histological 
mounting) are labelled. The vertical dashed white lines mark the approximate zones commonly used to denote organisation of the cartilage (synovial zone, transition 
or mid-zone and deep or calcified zone). b) DCLS analysis of the distribution of sGAGs across the same cartilage sections illustrating the marked differences in 
distribution between the normal (control) cartilage and the apparently normal cartilage sites in the joint with the lesion. c) Fluorescence distributions across the 
cartilage sections shown in a). The fluorescence signals were obtained from the areas subtracted from the raw Raman spectra during baseline correction. The folds in 
the cartilage appear as highly fluorescent artefacts that project beyond the boundary of the deep zone. 
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the ideal shape to probe the femoral condyle at knee flexion. However, 
further development of the optical probes should include the incorpo-
ration of design features tuned to the topography of the cartilage surface 
within the joint to enable the acquisition of spectra from distal or 
proximal regions of the condyles and the trochlear groove. It may be 
possible to develop probes based on fibre optics to deliver a laser beam 
and collect Raman photons within the hooked end of an arthroscopic 
probe. The main challenges are to enhance the collection efficiency of 
the probe for the rapid acquisition of spectra that span a wide range of 
Raman shifts and map a wider area. The development of fibre arrays, 
adaptive-focus optical fibre tips and fibre tip fabrication may overcome 
some of these challenges [68–72]. 
3.4. Raman mapping studies of cartilage 
Our initial studies revealed the limitations of point spectra for 
cartilage assessment. Further problems arise with this approach because 
of the anisotropic biomolecular composition of cartilage; variations in 
content are known to occur through its depth from the synovial surface 
to the subchondral bone [6,73]. The thinning of cartilage, observed with 
age and OA, further undermines the value of point measurements in 
evaluating disease-related changes. For example, changes in the pro-
portion of collagen to proteoglycans may influence the absolute in-
tensity of the phenylalanine ring breathing vibration at 1003 cm–1, as 
this residue is present in different amounts in the two protein compo-
nents. In addition, we have observed changes in the intensity, Raman 
shift and width of the S-O stretching band as a function of tissue 
degradation (Fig. 1). These confounding factors need careful consider-
ation to properly evaluate the issues that might affect the interpretation 
of articular cartilage spectra. We therefore conducted Raman mapping 
of the axial plane of cartilage specimens (synovial surface to sub-
chondral bone) to track the spatial localisation and relative abundance 
of sGAGs across the margins of lesion sites (Fig. 5a). 
To assess the relative abundance and distribution of sGAGs, we used 
a DCLS analysis with input reference Raman spectra for the main 
cartilage constituents to compare the Raman maps of the control and 
lesion sites (Fig. 5b). sGAGs in the healthy control cartilage were pre-
dominantly localised in the middle-to-deep zone, with a uniform spatial 
distribution (Fig. 5b, control). The heat maps indicate that compared to 
the control, in cartilage that was distal to a lesion site that had a 
macroscopically normal appearance, the sGAG distribution was less 
uniform and the concentrations lower (Fig. 5b, distal). However, in 
cartilage adjacent to the lesion, the sGAG distribution was even more 
heterogeneous, with localised regions of reduced or elevated sGAG 
concentration (Fig. 5b, adjacent). Within the lesion, where the structural 
integrity of the cartilage was compromised, the sGAG concentration was 
higher in the deeper zone than in the superficial zone, where the heat 
map showed the lowest concentrations (Fig. 5b, lesion). The varying 
levels of sGAG within the cartilage zones and between cartilage sites 
may be indicative of localised regions with varying degrees of proteo-
glycan loss or biosynthetic activity. Although mechanisms for both 
proteoglycan loss and biosynthetic activity have been shown to operate 
in cartilage disease models using biochemical assay methods, the sub-
millimetre spatial resolution of our Raman maps provides a more 
detailed picture of the underlying molecular alterations within lesions 
and in the apparently healthy adjacent cartilage. Furthermore, the focal 
loss of sGAG observed in the cartilage adjacent to the margin of a lesion 
supports the findings of our in-clinic study in which a decrease in sGAGs 
was observed in macroscopically normal cartilage adjacent to lesions. 
The Raman mapping studies provided a better insight into the 
cartilage fluorescence observed in the difference spectra in the previous 
analysis. The control sample exhibited the lowest fluorescence in-
tensities across all cartilage zones (Fig. 5c, control), compared to the 
corresponding zones in the macroscopically normal cartilage sampled 
from sites adjacent and distal to the lesion site. (Fig. 5c, adjacent and 
distal). The fluorescence emission signal was more intense in the 
superficial zone in both the adjacent and distal cartilage, and among 
these two specimens, the increase was more gradual for the cartilage 
proximal to the lesion. We speculate that these differences in spectra 
between normal cartilage and cartilage that is of normal appearance but 
from a joint with a small lesion suggest that the lesion influences the 
joint milieu across the whole joint to induce metabolic changes. 
Furthermore, the fluorescence intensity was diminished at the surface of 
the residual cartilage in the lesion (fibrillated cartilage) compared to 
that in the deep zone below the lesion (Fig. 5c, lesion). The greater level 
of detail on fluorescence localisation across a large region of cartilage 
provided by this type of mapping study could lead to a better under-
standing of the dynamic metabolic changes governing cartilage com-
ponents such as AGEs. Cartilage accumulates AGEs, which are 
fluorescent derivatives arising from non-enzymatic modification of 
amino groups by non-reducing sugars [57,56]. Cartilage collagen, which 
has a half-life of over 100 years, is prone to AGE accumulation due to its 
slow turnover [74]; hence, it is plausible that the lower fluorescence 
intensity within the fibrillating site may be associated with collagen loss 
by proteolytic action and faster tissue remodelling compared to normal 
(healthy) cartilage. The half-life of aggrecan is shorter, having been 
measured in cartilage as 3.4 years, although degradation products from 
its amino-terminus region can accumulate with age in smaller amounts 
[7] and exhibit a half-life of 25 years [75]. Consequently, its contribu-
tion to AGE-related fluorescence may be less prominent than that of 
collagen. 
The mapping results demonstrate that substantial differences exist 
between healthy young cartilage and macroscopically normal cartilage 
from a joint with a spontaneous local lesion. This warrants further 
investigation. Specifically, whether joints with more advanced lesions 
have distinct biochemical differences in the unaffected cartilage should 
be definitively established. A natural extension to this work would be to 
investigate the age-related biochemical differences in cartilage from 
young and old donors without lesions, to establish a baseline that will 
further substantiate the suitability of the use of various control cartilage 
specimens. Nevertheless, the observed differences in the concentrations 
and distributions of sGAGs indicate that Raman mapping studies of 
cartilage are not only essential for the assessment of specific molecular 
constituent distributions through its zonal structure, but also offer the 
potential to quantify concentrations and understand the significance for 
cartilage health of the biochemical alterations. The current Raman 
mapping technique is limited to ex vivo analysis of cartilage specimens 
but has the potential to be developed further to inform in vivo studies in 
which Raman-based optical probes are to be utilised. It would also be an 
invaluable imaging system for quality and process control in tissue en-
gineering strategies, facilitating the live monitoring of product quality. 
The Raman mapping study produced superior topographical detail 
across a wide area of cartilage that would have been impossible to obtain 
with commonly used single-point approaches. This is of significance 
because of the anisotropic nature of cartilage, where pathology-related 
molecular alterations need to be carefully distinguished from normal 
spatial variations in tissue biochemistry. 
4. Conclusion 
Our study extends earlier work and increases the certainty that 
clinically relevant changes in molecular species that precede macro-
scopic cartilage degeneration are detectable by Raman spectroscopy in 
the fingerprint wavenumber region. More specifically, in this work we 
established that it is possible to assess quantitatively the loss of -OSO3- 
groups from sGAGs together with changes in tissue hydration in carti-
lage containing small focal lesions. In addition, changes in multiple 
bands across the fingerprint region can provide a more comprehensive 
analysis of biosynthetic and catabolic processes in more advanced dis-
ease stages It is noteworthy that fingerprint-region Raman spectra can 
be recorded in joints of patients. This result is of significant value in 
highlighting the potential for further development of Raman techniques 
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for clinical use. The ability to record clinically useful Raman maps with 
sub-millimetre resolution in vivo has important implications for the 
topographical assessment of cartilage health across the joint, particu-
larly with respect to therapeutic options and disease progression. 
Furthermore, validation of this technique is necessary for its successful 
integration into clinical practice and could proceed by exploring the 
impact of several different experimental parameters such as variations in 
signal output at different depths of probing. It will also be of interest to 
explore the value of methyl and methylene C-H stretch Raman signals in 
the high-wavenumber region, as we have shown that these vibrational 
bands can allow better discrimination of samples with earlier compo-
sitional changes. 
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